IQVIA Holdings Inc. IQV
274.53 USD -0.62 (-0.23%)
At closeNov 11, 2026, 5:05 PM EST
274.53 0.00 0.00%
After hours · Nov 11, 5:05 PM ET
274.33 Day range 281.24
154.50 52-week range 284.50
- YTD
- +21.79%
- 1 year
- +25.63%
News
fool.com IQVIA: 3 Key Takeaways for Long-Term Investors Net new clinical bookings reached $3.2 billion in the third quarter. Last 12-month net new bookings increased 14% to $11.7 billion.
benzinga.com TD Cowen Maintains Buy on IQVIA Holdings, Raises Price Target to $307 TD Cowen analyst Charles Rhyee maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $288 to $307.
seekingalpha.com Artisan Global Value Fund Q3 2026 Portfolio Discussion US government debt-to-GDP exceeds 120%, while annual interest payments now surpass the budget for national defense. Our three best-performing stocks this quarter were Meta, IQVIA and Shell. Our three…
zacks.com Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
benzinga.com JP Morgan Maintains Overweight on IQVIA Holdings, Raises Price Target to $325 JP Morgan analyst Casey Woodring maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $295 to $325.- benzinga.com Truist Securities Maintains Buy on IQVIA Holdings, Raises Price Target to $346 Truist Securities analyst Jailendra Singh maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $329 to $346.
benzinga.com Evercore ISI Group Maintains Outperform on IQVIA Holdings, Raises Price Target to $310 Evercore ISI Group analyst Elizabeth Anderson maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $290 to $310.- benzinga.com Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $328 Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $324 to $328.
defenseworld.net IQVIA Holdings Inc. $IQV Stock Purchased by Citizens Financial Group Inc. RI Citizens Financial Group Inc. RI increased its holdings in shares of IQVIA Holdings Inc. (NYSE: IQV) by 67.8% in the third quarter, according to the company in its most recent Form 13F filing with…
marketbeat.com What IQVIA (IQV) Said on Its Q3 Earnings Call IQVIA NYSE: IQV reported third-quarter results that exceeded the high end of its guidance ranges, supported by accelerating organic growth in its Commercial Solutions and R&D Solutions businesses,…
zacks.com IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y IQV's Q3'26 earnings beat estimates as revenues rise 8% y/y, led by strong clinical demand, robust R&D bookings and improved execution, prompting a view hike.
benzinga.com IQVIA Hldgs Q3 2026 Earnings Call Transcript IQVIA Hldgs (NYSE:IQV) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates IQVIA Holdings (IQV) came out with quarterly earnings of $3.34 per share, beating the Zacks Consensus Estimate of $3.24 per share. This compares to earnings of $3 per share a year ago.
gurufocus.com IQVIA Reports Third-Quarter 2026 Results IQVIA Holdings Inc. (âIQVIAâ) (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the li- benzinga.com IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.80-$13.00 to $12.90-$13.00 vs $12.96 Est; Raises FY2026 Sales Guidance from $17.275B-$17.475B to $17.350B-$17.500B vs $17.419B Est IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.80-$13.00 to $12.90-$13.00 vs $12.96 analyst estimate. Raises FY2026 sales outlook from $17.275 billion-$17.475 billion to $17.350…
businesswire.com IQVIA Reports Third-Quarter 2026 Results RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to…
zacks.com IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know IQV is poised for y/y revenue and earnings growth in Q3, driven by stronger clinical research demand, solid bookings, AI adoption and operational efficiencies.
seekingalpha.com IQVIA: R&D Bookings Are Reaccelerating, But The Valuation Now Requires Execution IQVIA Holdings (IQV) is rated Buy, supported by strong Q2 results and a robust R&D bookings recovery. Q2 revenue grew 8.7% to $4.37B, with adjusted EPS up 12.1% and R&D net new bookings surging 19%…
zacks.com IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
defenseworld.net IQVIA Holdings Inc. $IQV Stock: Maia Wealth LLC Reduces Stake Maia Wealth LLC trimmed its position in shares of IQVIA Holdings Inc. (NYSE: IQV) by 44.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange…
defenseworld.net First Citizens Bank & Trust Co. Makes New $1.39 Million Investment in IQVIA Holdings Inc. $IQV First Citizens Bank and Trust Co. acquired a new position in shares of IQVIA Holdings Inc. (NYSE: IQV) in the third quarter, according to its most recent disclosure with the Securities and Exchange…
benzinga.com Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $303 Stifel analyst Shlomo Rosenbaum maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $276 to $303.
benzinga.com IQVIA Expands Partnership Veeva Systems On Enterprise Standard Applications That Will Be Used Across IQVIA Clinical Development Studies IQVIA (NYSE:IQV) and Veeva Systems (NYSE:VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard…
prnewswire.com IQVIA Selects Veeva Clinical Operations Applications RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif.- businesswire.com IQVIA Selects Veeva Clinical Operations Applications RESEARCH TRIANGLE PARK, N.C. & PLEASANTON, Calif.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) and Veeva Systems (NYSE: VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS,…
zacks.com Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
businesswire.com IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and…
businesswire.com IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and…
benzinga.com Mizuho Maintains Outperform on IQVIA Holdings, Raises Price Target to $300 Mizuho analyst Ann Hynes maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $275 to $300.- benzinga.com Barclays Maintains Overweight on IQVIA Holdings, Raises Price Target to $300 Barclays analyst Luke Sergott maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $275 to $300.
zacks.com Extensive Database & Solid Bookings Benefit IQVIA Amid Low Liquidity IQV's vast healthcare database, AI-enabled capabilities and strong R&DS bookings support growth, while low liquidity and $14.1B net debt remain in focus.
benzinga.com RBC Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $319 RBC Capital analyst Ryan Halsted maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $247 to $319.
benzinga.com Truist Securities Reiterates Buy on IQVIA Holdings, Raises Price Target to $329 Truist Securities analyst Jailendra Singh reiterates IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $300 to $329.- benzinga.com Morgan Stanley Maintains Equal-Weight on IQVIA Holdings, Raises Price Target to $270 Morgan Stanley analyst Kallum Titchmarsh maintains IQVIA Holdings (NYSE:IQV) with a Equal-Weight and raises the price target from $240 to $270.
- benzinga.com JP Morgan Maintains Overweight on IQVIA Holdings, Raises Price Target to $285 JP Morgan analyst Casey Woodring maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $225 to $285.
- benzinga.com Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $276 Stifel analyst Shlomo Rosenbaum maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $220 to $276.
- benzinga.com TD Cowen Maintains Buy on IQVIA Holdings, Raises Price Target to $288 TD Cowen analyst Charles Rhyee maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $233 to $288.
benzinga.com RBC Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $247 RBC Capital analyst Ryan Halsted maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $221 to $247.- benzinga.com BMO Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $270 BMO Capital analyst Sean Dodge maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $210 to $270.
- benzinga.com Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $287 Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $252 to $287.
benzinga.com Nasdaq 100 Enters Correction, SanDisk Sinks Over 50% From Peak: Stock Market Today A deepening chip rout drags the Nasdaq while Coca-Cola and Sherwin-Williams beats power the Dow; oil dives 5% on Iran diplomacy as the Fed meets.
benzinga.com Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting better-than-expected earnings and raising FY26 guidance.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Gossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $97.4 million. Prelude Therapeutics (NASDAQ:PRLD)…- benzinga.com IQVIA Hldgs Q2 Adj. EPS $3.15 Beats $3.03 Estimate, Sales $4.368B Beat $4.301B Estimate IQVIA Hldgs (NYSE:IQV) reported quarterly earnings of $3.15 per share which beat the analyst consensus estimate of $3.03 by 3.96 percent. This is a 12.1 percent increase over earnings of $2.81 per…
- benzinga.com IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 Est; Raises FY2026 Sales Guidance from $17.150B-$17.350B to $17.275B-$17.475B vs $17.286B Est IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 analyst estimate. Raises FY2026 sales outlook from $17.150 billion-$17.350 billion to $17.275…
- benzinga.com Mizuho Maintains Outperform on IQVIA Holdings, Raises Price Target to $230 Mizuho analyst Ann Hynes maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $215 to $230.
benzinga.com Palo Alto To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, please see our analyst ratings page.
benzinga.com Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $249 Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $230 to $249.
benzinga.com Micron To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday Top analysts changed outlook on top names: Intuit downgraded, Alkermes price target raised, Carmax target increased, Sezzle target up, Biogen target raised, Progressive target cut.- benzinga.com Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday Top Wall Street analysts changed outlook on top names. Baird raised prices for Ryder System and J B Hunt, Needham for Glaukos, B of A for CSX, Morgan Stanley for Charles River, and Bernstein for…